1 / 75

CHAPTER 13: Renal Transplantation

CHAPTER 13: Renal Transplantation. Rosnawati Yahya Goh Bak Leong Fan Kin Sing Rohan Malek Bin Dato’ Dr. Johan S. Prasad Menon Tan Si Yen Wong Hin Seng. Source: 21 st MDTR Report 2013, NRR. Table 13.1.1: Stock and flow of renal transplantation, 2004-2013.

amalie
Download Presentation

CHAPTER 13: Renal Transplantation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CHAPTER 13:Renal Transplantation Rosnawati Yahya Goh Bak Leong Fan Kin Sing Rohan Malek Bin Dato’ Dr. Johan S. Prasad Menon Tan Si Yen Wong Hin Seng Source: 21st MDTR Report 2013, NRR

  2. Table 13.1.1: Stock and flow of renal transplantation, 2004-2013 Source: 21st MDTR Report 2013, NRR

  3. Figure 13.1.1: Stock and flow of renal transplantation, 2004-2013 New patients Functioning graft at 31st Dec 2,000 1,800 1,600 1,400 1,200 No. of patients 1,000 800 600 400 200 0 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Year Source: 21st MDTR Report 2013, NRR

  4. Table 13.1.2: New transplant rate per million population (pmp), 2004-2013 Source: 21st MDTR Report 2013, NRR

  5. Figure 13.1.2: New transplant rate, 2004-2013 Source: 21st MDTR Report 2013, NRR

  6. Table 13.1.3: Transplant prevalence rate per million population (pmp), 2004-2013 Source: 21st MDTR Report 2013, NRR

  7. Figure 13.1.3: Transplant prevalence rate, 2004-2013 Source: 21st MDTR Report 2013, NRR

  8. Table 13.1.4: Place of transplantation, 2004-2013 Source: 21st MDTR Report 2013, NRR

  9. Figure 13.1.4(a): Places of transplantation, 2004-2013 Source: 21st MDTR Report 2013, NRR

  10. Figure 13.1.4(b): Place of transplantation within Malaysia Source: 21st MDTR Report 2013, NRR

  11. Table 13.2.1: Renal transplant recipients’ characteristics, 2004-2013 Source: 21st MDTR Report 2013, NRR

  12. Table 13.2.2: Primary causes of end stage renal failure, 2004-2013 Source: 21st MDTR Report 2013, NRR

  13. Table 13.3.1: Type of renal transplantation, 2004-2013 *Commercial Cadaver (China, India, other oversea) *Commercial live donor (living unrelated) *Cadaver (local) Source: 21st MDTR Report 2013, NRR

  14. Table 13.3.2: Biochemical data, 2009-2013 Source: 21st MDTR Report 2013, NRR

  15. Table 13.3.3: Immunosuppressive Medications, 2009-2013 Source: 21st MDTR Report 2013, NRR

  16. Table 13.3.4: Non-immunosuppressive medications, 2009-2013 Source: 21st MDTR Report 2013, NRR

  17. Table 13.4.1: Post-transplant complications, 2009-2013 *Hypertension: BP systolic >140 and BP diastolic >90 or have either Beta blocker/ Calcium channel blocker / ACE inhibitor / AIIRB / Other anti-hypertensive Source: 21st MDTR Report 2013, NRR

  18. Table 13.4.2: Transplant patient death rate and graft loss, 2004-2013 *Graft loss=graft failure *All losses=death / graft loss (acute rejection happens concurrently with graft failure / death) Source: 21st MDTR Report 2013, NRR

  19. Figure 13.4.2(a): Transplant recipient death rate, 2004-2013 Source: 21st MDTR Report 2013, NRR

  20. Figure 13.4.2(b): Transplant recipient graft loss rate, 2004-2013 Source: 21st MDTR Report 2013, NRR

  21. Table 13.4.3: Causes of death in transplant recipients, 2004-2013 Source: 21st MDTR Report 2013, NRR

  22. Table 13.4.4: Causes of graft failure, 2004-2013 Source: 21st MDTR Report 2013, NRR

  23. Table 13.5.1(a): Patient survival, 2004-2013 *n=Number at risk SE=standard error Source: 21st MDTR Report 2013, NRR

  24. Figure 13.5.1(a): Patient survival, 2004-2013 Source: 21st MDTR Report 2013, NRR

  25. Table 13.5.1(b): Risk factors for transplant patient survival 2004-2013 Source: 21st MDTR Report 2013, NRR

  26. Table 13.5.2(a): Graft survival, 2004-2013 *n=Number at risk SE=standard error Source: 21st MDTR Report 2013, NRR

  27. Figure 13.5.2(a): Graft survival, 2004-2013 Source: 21st MDTR Report 2013, NRR

  28. Table 13.5.2(b): Risk factors for transplant graft survival 2004-2013 Source: 21st MDTR Report 2013, NRR

  29. Table 13.5.3: Unadjusted patient survival by type of transplant, 2004-2013 *n=Number at risk SE=standard error Source: 21st MDTR Report 2013, NRR

  30. Figure 13.5.3: Patient survival by type of transplant, 2004-2013 Source: 21st MDTR Report 2013, NRR

  31. Table 13.5.4: Graft survival by type of transplant, 2004-2013 *n=Number at risk SE=standard error Source: 21st MDTR Report 2013, NRR

  32. Figure 13.5.4: Graft survival by type of transplants, 2004-2013 Source: 21st MDTR Report 2013, NRR

  33. Table 13.5.5(a): Patient survival by year of transplant (Living related transplant, 2004-2013) *n=Number at risk SE=standard error Source: 21st MDTR Report 2013, NRR

  34. Figure 13.5.5(a): Patient survival by year of transplant (Living related transplant, 2004-2013) Source: 21st MDTR Report 2013, NRR

  35. Table 13.5.5(b): Graft survival by year of transplant (Living related transplant, 2004-2013) *n=Number at risk SE=standard error Source: 21st MDTR Report 2013, NRR

  36. Figure 13.5.5(b): Graft survival by year of transplant (Living related transplant, 2004-2013) Source: 21st MDTR Report 2013, NRR

  37. Table 13.5.6(a): Patient survival by year of transplant (Commercial cadaver transplant, 2004-2013) *n=Number at risk SE=standard error Source: 21st MDTR Report 2013, NRR

  38. Figure 13.5.6(a): Patient survival by year of transplant (Commercial cadaver transplant, 2004-2013) Source: 21st MDTR Report 2013, NRR

  39. Table 13.5.6(b): Graft survival by year of transplant (Commercial cadaver transplant, 2004-2013) *n=Number at risk SE=standard error Source: 21st MDTR Report 2013, NRR

  40. Figure 13.5.6(b): Graft survival by year of transplant (Commercial cadaver transplant, 2004-2013) Source: 21st MDTR Report 2013, NRR

  41. Table 13.6.1: Risk factors for IHD in renal transplant recipients at year 2009-2013 **Hypertension: BP systolic > 140 and BP diastolic > 90 OR have either Beta blocker / Calcium channel blocker / ACE inhibitor / AIIRB / Other anti-hypertensive drugs GFR (mL/min/1.73m2) = 1.2*(140-age(year))*weight(kg) / creatinine (µmol/L) if male GFR (mL/min/1.73m2) = 0.85*(1.2*(140-age(year))*weight(kg) / creatinine (µmol/L) if female CKD stage III-GFR, 30-60 CKD stage IV-GFR, 15-30 CKD stage V-GFR, <15 Source: 21st MDTR Report 2013, NRR

  42. Figure 13.6.1(a): Venn diagram for pre and post transplant complications (in %) at year 2009 10.4 29.6 1.2 5.6 1.8 40.9 10.5 DM HPT CKD Source: 21st MDTR Report 2013, NRR

  43. Figure 13.6.1(b): Venn diagram for pre and post transplant complications (in %) at year 2010 CKD 10.1 30.5 1.4 6.5 2.2 37.7 11.7 DM HPT Source: 21st MDTR Report 2013, NRR

  44. Figure 13.6.1(c): Venn diagram for pre and post transplant complications (in %) at year 2011 CKD 8.7 29.5 1.8 6.1 2.2 39.3 12.5 HPT DM Source: 21st MDTR Report 2013, NRR

  45. Figure 13.6.1(d): Venn diagram for pre and post transplant complications (in %) at year 2012 CKD 13.1 28 1.9 6.1 2.1 36.5 12.4 HPT DM Source: 21st MDTR Report 2013, NRR

  46. Figure 13.6.1(e): Venn diagram for pre and post transplant complications (in %) at year 2013 CKD 12.3 29.8 1.6 6.2 2.6 37 10.5 DM HPT Source: 21st MDTR Report 2013, NRR

  47. Table 13.6.2(a): Systolic BP, 2009-2013 Source: 21st MDTR Report 2013, NRR

  48. Figure 13.6.2(a): Systolic BP, 2009-2013 Systolic BP <120 Systolic BP 120-129 Systolic BP 130-139 Systolic BP 140-159 Systolic BP 160-179 Systolic BP >=180 100 80 60 Percent 40 20 0 2009 2010 2011 2012 2013 Year Source: 21st MDTR Report 2013, NRR

  49. Table 13.6.2(b): Diastolic BP, 2009-2013 Source: 21st MDTR Report 2013, NRR

  50. Figure 13.6.2(b): Diastolic BP, 2009-2013 Diastolic BP <80 Diastolic BP <85 Diastolic BP 85-89 Diastolic BP 90-99 Diastolic BP 100-109 Diastolic BP >=110 100 80 60 Percent 40 20 0 2009 2010 2011 2012 2013 Year Source: 21st MDTR Report 2013, NRR

More Related